Donoghue Forlines’s iShares US Medical Devices ETF IHI Stock Holding History

Donoghue Forlines’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-364,908	Closed	-$12.2M	–	127
2018 Q4	$12.2M	Sell	364,908 -908,892	-71%	-$31.5M	1.09%	17
2018 Q3	$48.3M	Buy	+1,273,800	New	+$45.3M	3.77%	2

Other funds holding IHI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

AssetMark Inc Concord, California $49B AUM 17.78% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Donoghue Forlines's IHI Position: Q1 2019 in Review

Donoghue Forlines sold out of iShares US Medical Devices ETF (IHI) in Q1 2019, closing a stake of 364,908 shares — an estimated $12.2M sold.

Donoghue Forlines first reported a position in IHI in Q3 2018 and held it in 2 quarters. The position peaked at $48.3M in Q3 2018. 274 funds tracked by Wall St. Rank hold IHI as of Q1 2019.

Donoghue Forlines reported no remaining iShares US Medical Devices ETF position as of Q1 2019 after selling out during the quarter.
Donoghue Forlines sold 364,908 iShares US Medical Devices ETF shares in Q1 2019, an estimated $12.2M.
Donoghue Forlines first reported a position in iShares US Medical Devices ETF in Q3 2018 and held it in 2 quarters.
Donoghue Forlines's iShares US Medical Devices ETF position peaked at $48.3M in Q3 2018.
274 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q1 2019.

Based on Donoghue Forlines's 13F filing for Q1 2019, filed 12 Apr 2019.